Methods for genetic plant transformation using water-soluble fullerene derivatives
    2.
    发明授权
    Methods for genetic plant transformation using water-soluble fullerene derivatives 有权
    使用水溶性富勒烯衍生物进行遗传植物转化的方法

    公开(公告)号:US08614366B2

    公开(公告)日:2013-12-24

    申请号:US12876671

    申请日:2010-09-07

    申请人: Stephen R. Wilson

    发明人: Stephen R. Wilson

    IPC分类号: C07K14/415 B82Y30/00

    CPC分类号: C12N15/8201

    摘要: In various embodiments, methods described herein comprise the use of water-soluble cationic fullerene derivatives for improving plant genetic transformation. Cationic Fullerene derivatives of the invention possess DNA binding and compaction activity and provide a new method to deliver DNA into plant cells for plant transformation. Water-soluble fullerene derivatives of the invention with anionic or non-polar substituents possess antioxidant (free radical scavenging) activity, provide improved yields and efficiency of plant transformation methods such as biolistic, Agrobacterium tumefaciens, or electroporation methods by limiting cellular damage and resulting cell death leading to higher yields of viable transformed cells in the process.

    摘要翻译: 在各种实施方案中,本文所述的方法包括使用水溶性阳离子富勒烯衍生物来改善植物遗传转化。 本发明的阳离子富勒烯衍生物具有DNA结合和压实活性,并提供了将DNA输送到植物转化植物细胞中的新方法。 具有阴离子或非极性取代基的本发明的水溶性富勒烯衍生物具有抗氧化(自由基清除)活性,通过限制细胞损伤和产生的细胞提供植物转化方法如生物射弹,根癌土壤杆菌或电穿孔方法的提高的产量和效率 死亡导致该过程中可行的转化细胞的产量更高。

    Use of Carbon Nanotube for Drug Delivery
    5.
    发明申请
    Use of Carbon Nanotube for Drug Delivery 审中-公开
    碳纳米管用于药物输送

    公开(公告)号:US20080193490A1

    公开(公告)日:2008-08-14

    申请号:US11841087

    申请日:2007-08-20

    IPC分类号: A61K47/04 A61K9/00

    摘要: Compositions and methods for administering a therapeutic agent to a mammal are disclosed. The compositions comprise either (i) vesicles comprising an amphiphilic substituted fullerene, wherein the therapeutic agent is present in the vesicle interior or between layers of the vesicle wall, (ii) a substituted fullerene, comprising a fullerene core and a functional moiety, wherein the therapeutic agent is associated with the substituted fullerene, or (iii) carbon nanotubes, wherein the therapeutic agent is associated with the carbon nanotubes.

    摘要翻译: 公开了向哺乳动物施用治疗剂的组合物和方法。 所述组合物包含(i)包含两亲性取代的富勒烯的囊泡,其中所述治疗剂存在于泡囊内部或囊泡壁的层之间,(ii)包含富勒烯核心和功能部分的取代的富勒烯,其中 治疗剂与取代的富勒烯相关,或(iii)碳纳米管,其中治疗剂与碳纳米管相关联。